When the federal government decided to enact sweeping price controls on Medicare drugs, pundits and members of Congress crowed that the pharmaceutical industry was finally getting its comeuppance. They claimed that the new law, the Inflation Reduction Act, would make Medicare drugs more affordable and therefore more accessible to U.S. seniors. The only resulting harm […]
Author Archives: Robert Popovian
Robert Popovian is a senior visiting health policy fellow at the Pioneer Institute. He wrote this for InsideSources.com.
